Work

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(12)70335-2

Authors: Sophie Leboulleux, Lars Bastholt, Thomas Krause, Christelle de la Fouchardiere, Jan Tennvall, Ahmad Awada, José Manuel Gómez, Françoise Bonichon, Laurence Leenhardt, Christine Soufflet, Muriel Licour, Martin J Schlumberger

Institutions: Université Paris-Sud, Institut Gustave Roussy, Odense University Hospital, University Hospital of Bern, Hospices Civils de Lyon, Lund University, Skåne University Hospital, Université Libre de Bruxelles, Institut Jules Bordet, Bellvitge University Hospital, Institut Bergonié, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, AstraZeneca (France)

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2087614255

FWCI: 26.56

Cites: 29

Cited by: 380

Related to: 10